Status:

COMPLETED

Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma

Lead Sponsor:

Gleneagles Hospital

Collaborating Sponsors:

Singapore General Hospital

National Cancer Centre, Singapore

Conditions:

Multiple Myeloma

Eligibility:

All Genders

21+ years

Phase:

PHASE2

Brief Summary

The purpose of this study is to determine whether lower than conventional doses of dexamethasone and thalidomide; and a higher dosing frequency of zoledronic acid are effective in the treatment of new...

Detailed Description

Patients with newly-diagnosed multiple myeloma (MM) may be treated using monthly cycles of dexamethasone plus thalidomide (DT). Unfortunately, the use of conventional doses of DT is associated with si...

Eligibility Criteria

Inclusion

  • Age at or above 21 years
  • Clinical diagnosis of MM
  • Active MM with measurable disease
  • Signed written informed consent
  • Signed consent for drug safety program for thalidomide

Exclusion

  • Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
  • Patients with Indolent MM (IMM), or Smouldering MM (SMM)
  • Known hypersensitivity (including severe cutaneous reactions) to d, t or Z
  • Fulminant sepsis
  • Females in the reproductive age group who refuse contraception
  • Pregnancy
  • 24 hr urinary creatinine clearance time (CCT) \<30 ml/min
  • Previous renal transplantation
  • Severe peripheral neuropathy
  • Recurrent DVT or PE
  • Severe arrhythmias and cardiac conduction disorders
  • Liver dysfunction of active viral hepatitis
  • Osteonecrosis of the jaws (ONJ)

Key Trial Info

Start Date :

December 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2010

Estimated Enrollment :

56 Patients enrolled

Trial Details

Trial ID

NCT00263484

Start Date

December 1 2005

End Date

October 1 2010

Last Update

July 21 2011

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

Tata Memorial Hospital

Mumbai, Mumbai, India, 400 012

2

Christian Medical College

Vellore, Tamil Nadu, India, 632004

3

Singapore General Hospital

Singapore, Singapore, 169608

4

National Cancer Centre, Singapore

Singapore, Singapore, 169610

Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma | DecenTrialz